cervical cancer News
Most Popular cervical cancer Story
Merck's McGlynn has key role developing vaccines
BusinessWeek profiles Margaret McGlynn (photo), president of Merck Vaccines for the past 14 months. During that time, Merck has launched four vaccines, including Gardasil as a protection against cervical cancer. These vaccines are at the center of Merck's plans to revive the company from its post-Vioxx debacle. Gardasil alone is expected to generate $2 billion to $4 billion in annual revenue.
- here's the …
Read more...Latest Headlines
- September 28, 2007
- January 1, 2007
- October 18, 2006
- October 8, 2006
- August 24, 2006
- June 22, 2006
- June 13, 2006
- June 8, 2006
- May 25, 2006
- May 18, 2006
- May 17, 2006
- May 16, 2006
- March 8, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
